Advertisement

Topics

Alimera Sciences, Inc. Company Profile

23:50 EDT 25th September 2017 | BioPortfolio


News Articles [485 Associated News Articles listed on BioPortfolio]

Alimera, pSivida amend licensing agreement

Alimera Sciences may now seek approval of Iluvien for the secondary indication of posterior uveitis in the European Union, Middle East and Africa, according to a press release from the company.Alimera...

Financial Survey: Auxilium Pharmaceuticals

Auxilium Pharmaceuticals and Alimera Sciences are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institut...

Alimera Sciences Added To Russell 2000®, 3000® And Global Indexes

ATLANTA, July 1, 2013 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescript...

Sinovac Biotech (SVA) versus Alimera Sciences (ALIM) Head-To-Head Analysis

Sinovac Biotech and Alimera Sciences are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, ...

Alimera Sciences reports $6.7 million quarterly net loss

A first-quarter net loss of $6.7 million was reported by Alimera Sciences, compared with an $11.1 million net loss for the first quarter of 2016. Operating expenses went down from $14.2 million in 201...

Alimera Sciences Announces ILUVIEN Now Available In Ireland

  Life Sciences Jobs   ...

Alimera Sciences Announces Italian Patients Now Being Treated With ILUVIEN

  Life Sciences Jobs   ...

Alimera Sciences Reports Second Quarter 2017 Financial Results

  Life Sciences Jobs   ...

Clinical Trials [147 Associated Clinical Trials listed on BioPortfolio]

Cognitive Rehabilitation With C8 Sciences

C8 sciences program is a cognitive training program mainly developed for the students, and the effectiveness is well established. The aim of this trial is to assess clinical efficacy of th...

A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Sofosbuvir from Heterosofir 400 mg F.C.T (Pharmed Healthcare Co., Egypt) versus S...

The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid Leukemia

The purpose of this study is to evaluate that whether the AML (acute myeloid leukemia)-CAMS (Chinese Academy of Medical Sciences)-2016 regimen, includes risk-stratified therapy and the use...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

A Study of Sofosbuvir and Ledipasvir From Magicbuvir Plus 90/400 mg Tablets (Magic Pharma, Egypt) Versus Harvoni 90/400 mg Tablets (Gilead Sciences, USA)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir and Ledipasvir from M...

Companies [1017 Associated Companies listed on BioPortfolio]

Alimera Sciences

Our name, Alimera, is a loose combination of ancient Greek words with the intended meaning of "Day of Truth" and is founded on the underlying principles of honesty, integrity, responsibility, candor, ...

Alimera Sciences, Inc.

DVS Sciences, Inc.

DVS Sciences is a life sciences technology company that has developed and manufactures a novel technology for highly multiplexed analysis of single cells. DVS Sciences has an R&D ...

Origin Sciences Limited

Origin Sciences is a medical technology company developing innovative devices and tests to aid the detection and diagnosis of gastrointestinal diseases. Origin Sciences is based i...

T.A. Sciences

T.A. Sciences www.TASciences.com is the first company in the world to offer its clients the ability to fight aging through the emerging science of telomere biology. T.A. Sciences was founded by Noel T...

More Information about "Alimera Sciences, Inc." on BioPortfolio

We have published hundreds of Alimera Sciences, Inc. news stories on BioPortfolio along with dozens of Alimera Sciences, Inc. Clinical Trials and PubMed Articles about Alimera Sciences, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alimera Sciences, Inc. Companies in our database. You can also find out about relevant Alimera Sciences, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record